S&P 500   0.52 (-8.53%)
DOW   0.52 (-8.53%)
QQQ   270.38 (+0.37%)
AAPL   438.66 (+0.67%)
MSFT   213.29 (-1.50%)
FB   249.83 (-0.85%)
GOOGL   1,473.30 (-0.64%)
AMZN   3,138.83 (+0.87%)
NVDA   449.11 (+1.98%)
CGC   19.32 (+1.36%)
BABA   262.20 (+1.65%)
TSLA   1,487.00 (+0.13%)
MU   51.30 (+1.81%)
GE   6.14 (+0.49%)
AMD   85.04 (+9.49%)
T   30.01 (+1.32%)
F   6.86 (+2.54%)
ACB   10.73 (+2.98%)
GILD   70.88 (-1.18%)
NFLX   509.64 (+2.21%)
DIS   117.29 (+0.81%)
BAC   25.01 (+0.08%)
BA   165.07 (+1.73%)
S&P 500   0.52 (-8.53%)
DOW   0.52 (-8.53%)
QQQ   270.38 (+0.37%)
AAPL   438.66 (+0.67%)
MSFT   213.29 (-1.50%)
FB   249.83 (-0.85%)
GOOGL   1,473.30 (-0.64%)
AMZN   3,138.83 (+0.87%)
NVDA   449.11 (+1.98%)
CGC   19.32 (+1.36%)
BABA   262.20 (+1.65%)
TSLA   1,487.00 (+0.13%)
MU   51.30 (+1.81%)
GE   6.14 (+0.49%)
AMD   85.04 (+9.49%)
T   30.01 (+1.32%)
F   6.86 (+2.54%)
ACB   10.73 (+2.98%)
GILD   70.88 (-1.18%)
NFLX   509.64 (+2.21%)
DIS   117.29 (+0.81%)
BAC   25.01 (+0.08%)
BA   165.07 (+1.73%)
S&P 500   0.52 (-8.53%)
DOW   0.52 (-8.53%)
QQQ   270.38 (+0.37%)
AAPL   438.66 (+0.67%)
MSFT   213.29 (-1.50%)
FB   249.83 (-0.85%)
GOOGL   1,473.30 (-0.64%)
AMZN   3,138.83 (+0.87%)
NVDA   449.11 (+1.98%)
CGC   19.32 (+1.36%)
BABA   262.20 (+1.65%)
TSLA   1,487.00 (+0.13%)
MU   51.30 (+1.81%)
GE   6.14 (+0.49%)
AMD   85.04 (+9.49%)
T   30.01 (+1.32%)
F   6.86 (+2.54%)
ACB   10.73 (+2.98%)
GILD   70.88 (-1.18%)
NFLX   509.64 (+2.21%)
DIS   117.29 (+0.81%)
BAC   25.01 (+0.08%)
BA   165.07 (+1.73%)
S&P 500   0.52 (-8.53%)
DOW   0.52 (-8.53%)
QQQ   270.38 (+0.37%)
AAPL   438.66 (+0.67%)
MSFT   213.29 (-1.50%)
FB   249.83 (-0.85%)
GOOGL   1,473.30 (-0.64%)
AMZN   3,138.83 (+0.87%)
NVDA   449.11 (+1.98%)
CGC   19.32 (+1.36%)
BABA   262.20 (+1.65%)
TSLA   1,487.00 (+0.13%)
MU   51.30 (+1.81%)
GE   6.14 (+0.49%)
AMD   85.04 (+9.49%)
T   30.01 (+1.32%)
F   6.86 (+2.54%)
ACB   10.73 (+2.98%)
GILD   70.88 (-1.18%)
NFLX   509.64 (+2.21%)
DIS   117.29 (+0.81%)
BAC   25.01 (+0.08%)
BA   165.07 (+1.73%)
Log in

NYSE:CHEChemed Stock Price, Forecast & News

$502.89
+0.50 (+0.10 %)
(As of 08/4/2020 04:00 PM ET)
Add
Compare
Today's Range
$494.56
Now: $502.89
$507.49
50-Day Range
$435.24
MA: $466.74
$502.39
52-Week Range
$330.01
Now: $502.89
$513.75
Volume111,577 shs
Average Volume111,251 shs
Market Capitalization$7.98 billion
P/E Ratio31.61
Dividend Yield0.25%
Beta0.71
Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers in the United States. It operates through two segments, VITAS and Roto-Rooter. The company also offers plumbing, drain cleaning, water restoration, and other related services to residential and commercial customers through company-owned and independent contractors, and franchised locations. Chemed Corporation was founded in 1970 and is headquartered in Cincinnati, Ohio.
Read More
Chemed logo

Beat the Market (BTM) Rank

Analyst Opinion: 1.5Community Rank: 2.3Dividend Strength: 3.3Insider Behavior: 1.0Valuation: 0.6 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.75 out of 5 stars


Industry, Sector and Symbol

Industry Home health care services
Sub-IndustryHealth Care Services
SectorMedical
CUSIP16359R10
Phone513-762-6690

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$1.94 billion
Cash Flow$17.61 per share
Book Value$45.39 per share

Profitability

Net Income$219.92 million

Miscellaneous

Employees16,641
Market Cap$7.98 billion
Next Earnings Date11/3/2020 (Estimated)
OptionableOptionable
$502.89
+0.50 (+0.10 %)
(As of 08/4/2020 04:00 PM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive CHE News and Ratings via Email

Sign-up to receive the latest news and ratings for CHE and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Chemed (NYSE:CHE) Frequently Asked Questions

How has Chemed's stock been impacted by COVID-19 (Coronavirus)?

Chemed's stock was trading at $414.05 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization. Since then, CHE stock has increased by 21.5% and is now trading at $502.89.
View which stocks have been most impacted by Coronavirus
.

Do Wall Street analysts recommend investors buy shares of Chemed?

4 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Chemed in the last year. There are currently 4 buy ratings for the stock, resulting in a consensus recommendation of "Buy."
View analyst ratings for Chemed
.

When is Chemed's next earnings date?

Chemed is scheduled to release its next quarterly earnings announcement on Tuesday, November 3rd 2020.
View our earnings forecast for Chemed
.

How were Chemed's earnings last quarter?

Chemed Co. (NYSE:CHE) announced its earnings results on Wednesday, July, 29th. The company reported $4.41 earnings per share for the quarter, beating analysts' consensus estimates of $3.75 by $0.66. The company earned $502.20 million during the quarter, compared to analysts' expectations of $522.90 million. Chemed had a return on equity of 36.71% and a net margin of 12.99%. The company's quarterly revenue was up 6.0% on a year-over-year basis. During the same period last year, the company earned $3.36 EPS.
View Chemed's earnings history
.

How often does Chemed pay dividends? What is the dividend yield for Chemed?

Chemed declared a quarterly dividend on Tuesday, May 19th. Investors of record on Thursday, May 28th will be paid a dividend of $0.32 per share on Wednesday, June 17th. This represents a $1.28 dividend on an annualized basis and a yield of 0.25%. The ex-dividend date of this dividend is Wednesday, May 27th.
View Chemed's dividend history
.

What guidance has Chemed issued on next quarter's earnings?

Chemed updated its FY20 earnings guidance on Wednesday, July, 29th. The company provided earnings per share guidance of $16.20-16.40 for the period, compared to the Thomson Reuters consensus EPS estimate of $16.13.

What price target have analysts set for CHE?

4 analysts have issued 12 month target prices for Chemed's shares. Their forecasts range from $490.00 to $535.00. On average, they anticipate Chemed's share price to reach $515.00 in the next twelve months. This suggests a possible upside of 2.4% from the stock's current price.
View analysts' price targets for Chemed
.

Has Chemed been receiving favorable news coverage?

Media coverage about CHE stock has been trending somewhat positive on Tuesday, according to InfoTrie. The research group identifies positive and negative press coverage by monitoring more than six thousand news and blog sources in real time. The firm ranks coverage of public companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. Chemed earned a daily sentiment score of 0.8 on InfoTrie's scale. They also gave media stories about the company a news buzz of 10.0 out of 10, meaning that recent press coverage is extremely likely to have an effect on the stock's share price in the near future.
View the latest news about Chemed
.

Are investors shorting Chemed?

Chemed saw a decline in short interest in July. As of July 15th, there was short interest totaling 177,700 shares, a decline of 24.8% from the June 30th total of 236,200 shares. Based on an average trading volume of 109,700 shares, the short-interest ratio is currently 1.6 days. Currently, 1.2% of the shares of the company are sold short.
View Chemed's Current Options Chain
.

Who are some of Chemed's key competitors?

What other stocks do shareholders of Chemed own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Chemed investors own include AT&T (T), Home Depot (HD), Altria Group (MO), Target (TGT), Verizon Communications (VZ), AbbVie (ABBV), Boeing (BA), CVS Health (CVS), Chevron (CVX) and Johnson & Johnson (JNJ).

Who are Chemed's key executives?

Chemed's management team includes the following people:
  • Mr. Kevin J. McNamara, CEO, Pres & Director (Age 65)
  • Mr. David P. Williams, Exec. VP & CFO (Age 58)
  • Ms. Naomi C. Dallob, VP, Chief Legal Officer & Sec. (Age 65)
  • Mr. Spencer S. Lee, Exec. VP (Age 63)
  • Mr. Nicholas Michael Westfall, Exec. VP (Age 40)

What is Chemed's stock symbol?

Chemed trades on the New York Stock Exchange (NYSE) under the ticker symbol "CHE."

Who are Chemed's major shareholders?

Chemed's stock is owned by a variety of retail and institutional investors. Top institutional shareholders include Riverbridge Partners LLC (2.12%), Copeland Capital Management LLC (0.67%), First Trust Advisors LP (0.51%), Boston Trust Walden Corp (0.47%), Trinity Street Asset Management LLP (0.36%) and Envestnet Asset Management Inc. (0.30%). Company insiders that own Chemed stock include Andrea R Lindell, David Patrick Williams, Donald E Saunders, Frank E Wood, George J Walsh III, Kevin J Mcnamara, Michael D Witzeman, Naomi C Dallob, Nicholas Michael Westfall, Patrick P Grace, Spencer S Lee, Thomas P Rice and Walter L Krebs.
View institutional ownership trends for Chemed
.

Which major investors are selling Chemed stock?

CHE stock was sold by a variety of institutional investors in the last quarter, including Boston Trust Walden Corp, Riverbridge Partners LLC, Fort Washington Investment Advisors Inc. OH, First Trust Advisors LP, Raymond James Financial Services Advisors Inc., Robeco Institutional Asset Management B.V., NN Investment Partners Holdings N.V., and First Quadrant L P CA. Company insiders that have sold Chemed company stock in the last year include Andrea R Lindell, David Patrick Williams, Donald E Saunders, Frank E Wood, Kevin J Mcnamara, Michael D Witzeman, Naomi C Dallob, Patrick P Grace, Spencer S Lee, and Walter L Krebs.
View insider buying and selling activity for Chemed
.

Which major investors are buying Chemed stock?

CHE stock was purchased by a variety of institutional investors in the last quarter, including Trinity Street Asset Management LLP, Raymond James & Associates, Contravisory Investment Management Inc., Envestnet Asset Management Inc., UBS Group AG, Vident Investment Advisory LLC, Duality Advisers LP, and Empowered Funds LLC.
View insider buying and selling activity for Chemed
.

How do I buy shares of Chemed?

Shares of CHE can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Chemed's stock price today?

One share of CHE stock can currently be purchased for approximately $502.89.

How big of a company is Chemed?

Chemed has a market capitalization of $7.98 billion and generates $1.94 billion in revenue each year. The company earns $219.92 million in net income (profit) each year or $13.95 on an earnings per share basis. Chemed employs 16,641 workers across the globe.

What is Chemed's official website?

The official website for Chemed is www.chemed.com.

How can I contact Chemed?

Chemed's mailing address is 255 EAST FIFTH STREET SUITE 2600, CINCINNATI OH, 45202. The company can be reached via phone at 513-762-6690.

This page was last updated on 8/4/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.